BioPharm (United Kingdom)

Recent papers from BioPharm (United Kingdom)

1. Metabolism-Informed Bioreactor Model for Transferring Knowledge from Fed-batch to Continuous Biomanufacturing2026
2. PS5-06-02: Cdk4/6 inhibitor-induced interstitial lung disease: a rare but severe complication in breast cancer treatmentClinical Cancer Research · 2026
3. A Multi-Clone Kinetic Model for Characterising CHO Cell Line VariabilityJournal of Industrial Microbiology & Biotechnology · 2025
4. Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCsMolecular Cancer Therapeutics · 2025
5. Bifunctional and Uniform Tungsten Nanoparticles as a Dual-Mode Sensor for Quercetin and Ratiometric Detection of RiboflavinACS Applied Nano Materials · 2025
6. Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program of 1076 PatientsAmerican Journal of Respiratory and Critical Care Medicine · 2025
7. The GIN-McMaster Guideline Development Checklist extension for engagementENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2025
8. Rapid virucidal activity of an air sanitizer against aerosolized MS2 and Phi6 phage surrogates for non-enveloped and enveloped vertebrate viruses, including SARS-CoV-2Applied and Environmental Microbiology · 2024
9. Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligandsJournal of Computer-Aided Molecular Design · 2024
10. From UK-2A to florylpicoxamid: Active learning to identify a mimic of a macrocyclic natural productJournal of Computer-Aided Molecular Design · 2024
11. Exploring kidney dialysis costs in the United States: a scoping reviewJournal of Medical Economics · 2024
12. Modelling bronchial epithelial-fibroblast cross-talk in idiopathic pulmonary fibrosis (IPF) using a human-derived in vitro air liquid interface (ALI) cultureScientific Reports · 2024
13. A New One-Pot Synthesis of 3,6-Disubstituted Pyridazines Starting from β-Nitro-β,γ-Unsaturated KetonesSynthesis · 2023
14. Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratoryEuropean Journal of Pharmaceutics and Biopharmaceutics · 2023
15. Synthesis of Dibenzo[f,h]quinolines by Stepwise C–H Arylation of 2-Phenylpyridine and Reductive CyclodehydrogenationSynthesis · 2023
16. Data from Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD222023
17. A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid LeukemiaClinical Lymphoma Myeloma & Leukemia · 2023
18. Comprehensive studies on building a scalable downstream process for mRNAs to enable mRNA therapeuticsBiotechnology Progress · 2022
19. A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer ImmunotherapyFrontiers in Immunology · 2022
20. Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesisPLoS ONE · 2022